Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: insurance (continued)
- A.M. Vitals: Employers’ Health-Care Premiums Rose 9% This Year
- A.M. Vitals: FDA Adds a Warning, Removes Another From Statin Labels
- A.M. Vitals: FDA Cancer Division Head Defends Avastin Decision
- A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial
- A.M. Vitals: FDA Panel Votes to Strip Avastin’s Breast Cancer Indication
- A.M. Vitals: FDA Recommends Lower Doses of Zocor For Some
- A.M. Vitals: FDA Warns On Inferior Vena Cava Filters
- A.M. Vitals: Federal Medical Privacy Rules Go Back for Do-Over
- A.M. Vitals: France, Germany Halt Use of Takeda’s Actos
- A.M. Vitals: Frustrated ALS Patients Make Own Drug
- A.M. Vitals: Gene Therapy Treats Hemophilia B in Small Study
- A.M. Vitals: Genzyme Factory Fixes Will Take Longer Than Thought
- A.M. Vitals: Genzyme Says Sanofi Needs to Cough Up More Cash
- A.M. Vitals: Genzyme to Explore ‘Alternatives’ to Sanofi Bid
- A.M. Vitals: Genzyme, Sanofi Are Talking, But Nothing’s Guaranteed
- A.M. Vitals: Government Issues Rules on State Insurance Exchanges
- A.M. Vitals: HCA’s Results Show Sluggish Economy’s Effects on Hospitals
- A.M. Vitals: Health Insurers Diversify As Overhaul Trims Margins
- A.M. Vitals: Health-Law Debate Turns to Defining ‘Essential’ Care
- A.M. Vitals: Heart Health Report Card, Penalties for Smokers and Cheese Vs. Butter
- A.M. Vitals: HHS Will Exercise ‘Discretion’ on McDonald’s Insurance
- A.M. Vitals: House Votes to Repeal Health-Care Law
- A.M. Vitals: Humana Profit Up 21% On New Enrollment
- A.M. Vitals: Insurance Executives Say New Benefits Mean Higher Rates
- A.M. Vitals: Insurers Join the Electronic Medical Records Party
- A.M. Vitals: It’s Open Enrollment Season; Look for High Deductibles
- A.M. Vitals: J&J and Synthes Agree to $21.3 Billion Deal
- A.M. Vitals: J&J Sets Record With Corporate Bond Rates
- A.M. Vitals: J&J Shakes Up Oversight of McNeil Unit
- A.M. Vitals: J&J’s Weldon Saw 7% Drop in Total Compensation Last Year
- A.M. Vitals: Judge Blocks Federal Funding of Embryonic Stem Cell Research
- A.M. Vitals: Judge Won’t Nix Generic Version of Sanofi’s Lovenox
- A.M. Vitals: Kellogg Dinged for Claiming Rice Krispies Boost Immunity
- A.M. Vitals: Latest J&J Recall Involves Two DePuy Hip Implants
- A.M. Vitals: Lilly Focuses on Alzheimer’s, Diabetes, Cancer
- A.M. Vitals: Lilly Profit Beats Analysts’ Expectations (By a Penny)
- A.M. Vitals: Lilly’s 3Q Earnings Beat Expectations
- A.M. Vitals: Liver Warning For Glaxo’s Alli and Xenical Weight-Loss Drugs
- A.M. Vitals: Many Health Plans Might Lose ‘Grandfathered’ Status
- A.M. Vitals: McDonald’s Says it Needs Health Insurance Waiver
- A.M. Vitals: Medicaid Funding For States Clears the House
- A.M. Vitals: Merck Profit Falls 52% On Merger, Restructuring Costs
- A.M. Vitals: Merck’s First-Quarter Profit Beats Expectations
- A.M. Vitals: More Americans Uninsured
- A.M. Vitals: More J&J Products Scrutinized By Congress
- A.M. Vitals: New Lung-Cancer Screening Guidelines
- A.M. Vitals: Novartis Chairman Vasella Adds Same Title at Alcon
- A.M. Vitals: NYC Can’t Ban Soda Purchases Using Food Stamps
- A.M. Vitals: Obama Administration Will Promote One-Year-Old Health Bill
- A.M. Vitals: Omnicare’s Candid Earnings Call
- A.M. Vitals: Pfizer and Teva Report 3rd-Quarter Earnings
- A.M. Vitals: Pfizer Earnings Top Estimates, But Sales Miss
- A.M. Vitals: Pfizer Says Arthritis Trial Had One Drug-Related Death
- A.M. Vitals: Pfizer Stops Some Drug Trials; No ‘Doc Fix’ Yet
- A.M. Vitals: Pfizer Waits for Approval to Conduct Embryonic Stem-Cell Trial
- A.M. Vitals: Pfizer’s Read Keeps Key Leaders in Executive Shuffle
- A.M. Vitals: Physicians React to Decisions on Glaxo’s Avandia
- A.M. Vitals: Radiation Risk for Those Near Reactor in Japan
- A.M. Vitals: Repeated Head Blows Associated With ALS-Like Condition
- A.M. Vitals: Roche Bids $5.7 Billion For Illumina
- A.M. Vitals: Roche Lowers Sales Forecast for Avastin
- A.M. Vitals: Roche Third-Quarter Sales Fell 7.3%
- A.M. Vitals: Ryan, Wyden to Introduce Proposal for Changing Medicare
- A.M. Vitals: Sanofi Getting Financing Ready for Genzyme Bid
- A.M. Vitals: Sanofi Likely to Formally Offer to Buy Genzyme
- A.M. Vitals: Sanofi May Pay $74 Per Share Up Front for Genzyme
- A.M. Vitals: Sanofi Reports Breast Cancer Drug Setback
- A.M. Vitals: Sanofi, Genzyme Hope to (Finally) Ink Deal This Week
- A.M. Vitals: Sanofi’s 2011 Outlook Disappoints Investors
- A.M. Vitals: Searching for the Source of Lung Cancer in Women
- A.M. Vitals: Senators Push for Brand-Name-Friendly Biologics Policy
- A.M. Vitals: So Far, Radiation Risk in Japan is Low
- A.M. Vitals: States Can Decide on Essential Benefits for Health Plans
- A.M. Vitals: Study Suggests Colonoscopy Cuts Cancer Deaths
- A.M. Vitals: The iPad As Medical-Sector Sales Whiz
2009 -